New Zealand

Last Updated 26 July 2021.

2 Vaccines Approved for Use in New Zealand

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 97 countries

  24 trials in 16 countries

  Approval Source: medsafe.govt.nz

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  11 trials in 17 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

1 Vaccine in Clinical Trials in New Zealand

• Jiangsu Rec-Biotechnology Co Ltd
  ReCOV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Protein Subunit